Treatment of Schamberg's disease with pentoxifylline--therapeutic trial.
Indian J Dermatol Venereol Leprol
;
2003 Jan-Feb; 69(1): 25-6
Article
in English
| IMSEAR
| ID: sea-52080
ABSTRACT
Twenty patients with Schamberg's disease were started on pentoxifylline (400 mg once daily) for a period of 8 weeks. Improvement was assessed at 2 weekly intervals by two observers independently and graded as mild (< 25%, moderate (25-50%) and marked (>50%). Marked improvement was observed in 10/20(50%) patients. We conclude that pentoxifylline should be considered as first line therapy in all patients with Schamberg's disease.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Language:
English
Journal:
Indian J Dermatol Venereol Leprol
Year:
2003
Type:
Article
Similar
MEDLINE
...
LILACS
LIS